These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29532425)

  • 21. Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug Development.
    Mehta MU; Uppoor RS; Conner DP; Seo P; Vaidyanathan J; Volpe DA; Stier E; Chilukuri D; Dorantes A; Ghosh T; Mandula H; Raines K; Dhanormchitphong P; Woodcock J; Yu LX
    Mol Pharm; 2017 Dec; 14(12):4334-4338. PubMed ID: 29076742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Folic Acid.
    Hofsäss MA; Souza J; Silva-Barcellos NM; Bellavinha KR; Abrahamsson B; Cristofoletti R; Groot DW; Parr A; Langguth P; Polli JE; Shah VP; Tajiri T; Mehta MU; Dressman JB
    J Pharm Sci; 2017 Dec; 106(12):3421-3430. PubMed ID: 28842299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Permeability - Best Practices for Biopharmaceutics Classification System (BCS)-Based Biowaivers: A workshop Summary Report.
    Mehta M; Polli JE; Seo P; Bhoopathy S; Berginc K; Kristan K; Cook J; Dressman JB; Mandula H; Munshi U; Shanker R; Volpe DA; Gordon J; Veerasingham S; Welink J; Almeida S; Gonzalez P; Painter D; Tsang YC; Vaidyanathan J; Velagapudi R
    J Pharm Sci; 2023 Jul; 112(7):1749-1762. PubMed ID: 37142122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of rat jejunal permeability for biopharmaceutics classification system.
    Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Islambulchilar Z
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1496-502. PubMed ID: 19929209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Amoxicillin Trihydrate.
    Thambavita D; Galappatthy P; Mannapperuma U; Jayakody L; Cristofoletti R; Abrahamsson B; Groot DW; Langguth P; Mehta M; Parr A; Polli JE; Shah VP; Dressman J
    J Pharm Sci; 2017 Oct; 106(10):2930-2945. PubMed ID: 28483422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Evaluation of Valsartan Biopharmaceutics Properties.
    de Castro LML; de Souza J; Caldeira TG; de Carvalho Mapa B; Soares AFM; Pegorelli BG; Della Croce CC; Barcellos NMS
    Curr Drug Res Rev; 2020; 12(1):52-62. PubMed ID: 31820707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Situ Intestinal Perfusion in Rodents: Future Perspectives for Application on Absorption Studies and Classification of Drugs.
    Dezani TM; Dezani AB; de Silva MMC; Dos Reis Serra CH
    Mini Rev Med Chem; 2017; 17(9):746-757. PubMed ID: 27659249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
    Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
    Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen.
    Tsume Y; Langguth P; Garcia-Arieta A; Amidon GL
    Biopharm Drug Dispos; 2012 Oct; 33(7):366-77. PubMed ID: 22815122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biowaiver monographs for immediate release solid oral dosage forms: piroxicam.
    Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
    J Pharm Sci; 2014 Feb; 103(2):367-77. PubMed ID: 24301077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possibility of extending biopharmaceutics classification system based biowaiver to BCS class IIa drug.
    Khalid F; Hassan SMF; Noor R; Zaheer K; Hassan F
    Pak J Pharm Sci; 2019 Sep; 32(5):2065-2073. PubMed ID: 31813872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk assessment for extending the Biopharmaceutics Classification System-based biowaiver of immediate release dosage forms of fluconazole in adults to the paediatric population.
    Charoo NA; Cristofoletti R; Dressman JB
    J Pharm Pharmacol; 2015 Aug; 67(8):1156-69. PubMed ID: 25828546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.
    Takagi T; Ramachandran C; Bermejo M; Yamashita S; Yu LX; Amidon GL
    Mol Pharm; 2006; 3(6):631-43. PubMed ID: 17140251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Cephalexin Monohydrate.
    Plöger GF; Quizon PM; Abrahamsson B; Cristofoletti R; Groot DW; Parr A; Langguth P; Polli JE; Shah VP; Tajiri T; Mehta MU; Dressman J
    J Pharm Sci; 2020 Jun; 109(6):1846-1862. PubMed ID: 32240696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of the EMA change in definition of "dose" on the BCS dose-solubility ratio: a review of the biowaiver monographs.
    Sediq A; Kubbinga M; Langguth P; Dressman J
    J Pharm Sci; 2014 Jan; 103(1):65-70. PubMed ID: 24338749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating theoretical and experimental permeability estimations for provisional biopharmaceutical classification: Application to the WHO essential medicines.
    Cabrera-Pérez MÁ; Pham-The H; Cervera MF; Hernández-Armengol R; Miranda-Pérez de Alejo C; Brito-Ferrer Y
    Biopharm Drug Dispos; 2018 Jul; 39(7):354-368. PubMed ID: 30021059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of torasemide based on the Biopharmaceutics Classification System and evaluation of the FDA biowaiver provision for generic products of CLASS I drugs.
    Khan MZ; Rausl D; Radosević S; Filić D; Danilovski A; Dumić M; Knezević Z
    J Pharm Pharmacol; 2006 Nov; 58(11):1475-82. PubMed ID: 17132210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of five active ingredients of Er-Zhi-Wan, a traditional Chinese medicine water-honeyed pill, using the biopharmaceutics classification system.
    Cao X; Li H; Wang M; Ren X; Deng Y
    Biomed Chromatogr; 2020 Feb; 34(2):e4757. PubMed ID: 31755125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Justification of metformin hydrochloride biowaiver criteria based on bioequivalence study.
    Homsek I; Parojcić J; Dacević M; Petrović L; Jovanović D
    Arzneimittelforschung; 2010; 60(9):553-9. PubMed ID: 21117498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.